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Abstract
Mycobacterium tuberculosis infects a third of the world’s population. Primary tuberculosis involving active fast bacterial
replication is often followed by asymptomatic latent tuberculosis, which is characterised by slow or non-replicating bacteria.
Reactivation of the latent infection involving a switch back to active bacterial replication can lead to post-primary
transmissible tuberculosis. Mycobacterial mechanisms involved in slow growth or switching growth rate provide rational
targets for the development of new drugs against persistent mycobacterial infection. Using chemostat culture to control
growth rate, we screened a transposon mutant library by Transposon site hybridization (TraSH) selection to define the
genetic requirements for slow and fast growth of Mycobacterium bovis (BCG) and for the requirements of switching growth
rate. We identified 84 genes that are exclusively required for slow growth (69 hours doubling time) and 256 genes required
for switching from slow to fast growth. To validate these findings we performed experiments using individual M. tuberculosis
and M. bovis BCG knock out mutants. We have demonstrated that growth rate control is a carefully orchestrated process
which requires a distinct set of genes encoding several virulence determinants, gene regulators, and metabolic enzymes.
The mce1 locus appears to be a component of the switch to slow growth rate, which is consistent with the proposed role in
virulence of M. tuberculosis. These results suggest novel perspectives for unravelling the mechanisms involved in the switch
between acute and persistent TB infections and provide a means to study aspects of this important phenomenon in vitro.
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Introduction
With the average daily death toll from tuberculosis at 4,500 the
worldwide burden of this disease is overwhelming [1]. Control
measures are being severely thwarted by the worldwide spread of
antibiotic resistant strains of Mycobacterium tuberculosis. In 2008
WHO recorded the highest rates of multi-drug (MDR) resistant
strains of TB and the spread of a virtually untreatable form of the
disease caused by extensively resistant strains (X-DR) [1]. Novel
anti-TB drugs are urgently required which shorten the lengthy
drug regimen required to treat TB and also have activity against
drug resistant strains. The identification of genes which provide
essential but unique functions in M. tuberculosis greatly facilitates
drug discovery programs and also provides further information
about the complex biology of this highly successful pathogen.
Slow growth rate is amongst one of the remarkable features of
M. tuberculosis. This pathogen can only achieve a maximum growth
rate equivalent to a doubling time of about 16 hours in optimal
laboratory conditions whilst in the human host growth rates vary
upon the site and stage of infection. Tuberculosis is characterized
by two distinct phases an acute phase where the bacteria are
actively growing and a persistent phase where the bacteria are in a
slow growing or non-growing state [2]. This ability to persist for
decades in a state refractory to immune clearance but primed for
reactivation is key to the success of M. tuberculosis and represents an
important barrier to the control of tuberculosis as presently used
chemotherapies are largely inactive against non-dividing cells. The
identification of pathways and genes essential to establish and
maintain persistence would facilitate the development of drugs
which target this phase of infection.
Although very little is known about the state of the tubercle
bacillus during persistence, it is generally agreed that the organism
replicates slowly or not at all during this stage of disease. To study
this component of the biology of M. tuberculosis we utilized
chemostat culture as this is the only method available to control
growth rate. In addition, the use of continuous culture in a
chemostat offers many advantages over batch culture enabling the
experimenter to vary the growth rate whilst maintaining cells in a
constant physical and chemical environment. Our previous studies
into the physiology of Mycobacterium bovis BCG (the vaccine strain
of the tubercle bacillus) demonstrated that growth rate modulated
the biomass composition [3]. In addition, the transcriptomic
fingerprint for slow growing BCG showed a high correlation to the
profile of M. tuberculosis growing in a macrophage [4] and also TB
patient’s sputum [5].
Whilst transcriptomics has proved to be an excellent tool for
studying the response of microbes to the environment it has been
shown to have limited value in predicting the contribution of
individual genes to the fitness of M. tuberculosis [6,7]. The current
study aims to further probe the physiological and gene regulatory
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Transposon site hybridisation (TraSH) is a microarray based
transposon tracking strategy to monitor the fitness of mutants in
mixed populations under different conditions. This powerful
functional genomic tool was developed using M. tuberculosis and
has now been applied successfully to a variety of pathogens [8,9].
Sassetti and co-workers have used TraSH to identify essential
genes for the growth of M. tuberculosis in minimal glucose medium
[8] as well as infection of mice [10] and survival in a macrophage
[7]. We build on this work to identify genes required for slow and
fast growth on minimal glycerol media in the controlled
environment of a chemostat. This data provides an invaluable
resource for mycobacterial researchers and will facilitate the
characterisation of genes with unknown roles and provide further
functional clues for some important virulence genes.
Results and Discussion
Genes required for growth on Roisin’s glycerol minimal
media
In the experiments described by Sassetti et al (2003) transposon
libraries of M. tuberculosis and M. bovis BCG were constructed and
recovered on 7H10 agar and TraSH analysis was used to identify
genes which were essential for the survival of both species on this
media. The experiments described here used just the BCG
transposon library generated by Sassetti et al (2003) for TraSH
analysis to investigate the genetic basis of growth control in a
chemostat model. Initially we determined the genes that were
‘additionally essential’ for growth in the defined minimal media
used for chemostat cultivations: Roisin’s minimal broth. The
additionally essential genes discussed here are defined as genes
which were identified in this study as essential for growth of M.
bovis BCG on Roisin’s minimal glycerol medium but had not been
previously identified by Sassetti et al (2003) as essential for the
growth of M. bovis BCG and M. tuberculosis on 7H10 medium.
A late log phase culture of the BCG transposon library [8] was
inoculated into a 2 L bioreactor operated in batch mode. Cells
were harvested after the OD600 reached approximately 1.0. The
composition of the output mutant pools was compared by TraSH
as described using randomly labeled genomic DNA as a control
probe [10]. Microarray signals were analysed using a rank based
statistic, Rank products (RP) [11]. RP is a non-parametric
statistical method which has demonstrated robustness in micro-
array analysis and has been shown to have a higher sensitivity and
selectivity in comparison with t-test based statistical methods [12].
This method detects genes that consistently have the largest
positive or negative log-ratio.
Roisin’s media is a chemically defined glycerol-limited media
that contains only one source of carbon plus Tween 80 as a
dispersal agent, ammonia as a nitrogen source and lacks citrate,
biotin or pyridoxine [3]. In contrast 7H10 is composed of several
potential carbon sources including glutamic acid, glycerol, glucose,
oleic acid and bovine serum albumin and also contains the co-
factors biotin and pyridoxine hydrochloride and the buffer sodium
citrate facilitating citrate mediated iron transport. In the absence
of citrate mycobacteria grown on Roisin’s would be reliant on the
siderophore mycobactin for iron transport. We therefore expected
to find that the set of ‘additionally essential’ genes required to grow
on Roisin’s media to be principally those involved in glycerol
uptake and metabolism, ammonia uptake and genes required for
de novo biosynthesis of biotin, pyridoxine and mycobactin.
A total of 241 genes (Dataset S1) that were not essential for
survival in 7H10 media [8] were identified here as uniquely
required for growth in Roisin’s minimal medium. Several of these,
including MmpL3, ideR, embA, have previously been shown to be
essential for the growth of M. tuberculosis on media containing both
glucose and glycerol [13,14] so it is unclear why they were
identified as non-essential in the original screen performed by
Sassetti and colleagues (2003).
Under laboratory conditions glycerol is the favored carbon
source of M. tuberculosis and the vaccine strain M. bovis BCG.
Mycobacterium bovis, however is unable to use glycerol as a sole
carbon source as a result of a single nucleotide polymorphism in
the gene pykA [15]. During the creation of M. bovis BCG the serial
passaging of M. bovis on glycerinated medium selected for the
correction of this mutation [15]. The route for glycerol utilization
is generally assumed to proceed via glycerol kinase followed by
dehydrogenation [15]. However, many bacteria utilize an
alternative pathway whereby glycerol is first oxidized by glycerol
dehydrogenase before being phosphorylated [16]. Glycerol
dehydrogenase activity has been detected in M. tuberculosis [17],
but no gene encoding this activity has been annotated in the
genome and several genes encoding putative alcohol dehyro-
genases are also present. The results presented here show that glpK
was essential for growth on Roisin’s minimal glycerol media
(p=1.48610
22). To clarify the situation, and also to indepen-
dently validate the TraSH data, an individual gene knock-out of
glpK was constructed in both M. bovis BCG and M. tuberculosis. The
resulting mutants displayed a dysgonic growth phenotype when
grown on 7H11 media and failed to grow on Roisin’s agar
(Figure 1) confirming the TraSH result and indicating that the
glycerol kinase pathway is indeed essential for glycerol metabolism.
The experimental data indicated that, amongst biotin biosyn-
thetic genes, only bioD was essential for growth in the biotin free
Roisin’s media. However, bioA with a pfp value of 0.114 was just
below the cut-off value for essentiality. Surprisingly none of the
genes involved mycobactin synthesis were essential for growth in
Roisin’s minimal medium. M. tuberculosis is peculiar in its ability to
produce both cell-associated (mycobactin) and secreted (carbox-
ymycobactin) siderophores to capture iron. The cross feeding of
the mbt mutants by carboxymycobactin released from neighboring
cells may enable mbt mutants to overcome their siderphore
deficiency. However mbtB, which, encodes the enzyme required
for the initial steps in mycobactin T synthesis, had a pfp value of
0.21 and therefore may have a role in the optimal growth of
mycobacteria in this media. Deletion of the mbtB gene has been
shown to disrupt the biosynthesis of both mycobactin and
carboxymycobactin [18]. Cross feeding could also enable
pyridoxine synthesis mutants to overcome the inability to
synthesise this co-factor.
Comparison of glycerol essentiality results with flux
balance analysis (FBA) model predictions of a genome-
scale metabolic model
Genome-scale metabolic models provide a valuable framework
to interpret essentiality screens as they allow predictions of gene
essentiality using current knowledge of the metabolic network
whilst also providing an insight into incomplete or incorrect
metabolic knowledge. The glycerol TraSH results were compared
with gene essentiality predictions using a genome-scale metabolic
network of M. tuberculosis (GSMN-TB) [19]. The gene essentiality
scan was performed using the minimal biomass e as described
previously [19]. In addition the carbon source was changed to
glycerol and the biotin and citrate gates were closed. Overall there
was a good correlation between the GSMN-TB model and the
observed gene essentialities as 76.66% of the predictions were
identical to the experimental results (additionally essential genes
only). This analysis identified some interesting inconsistencies (false
BCG Growth Rate Control
PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5349positives and false negatives) which reveal important information
about the metabolism of tuberculosis and this information can also
be used to make informed alterations to the GSMN. The set of
false negatives (genes predicted as dispensable by the model but
shown to be essential experimentally) included genes which had
potential homologues with annotations of only moderate confi-
dence and maybe unable to replace the activity of their deleted
isoenzyme. For example, fabD which is a major component of M.
tuberculosis fatty acid synthase II has a possible homologue fabD2
which is present in the GSMN. The demonstration that fabD is
essential suggests that fabD2 is unable to functionally complement
the activities of fabD. Several genes were also predicted as
functionally redundant due to the presence in the model of
alternative pathways that can substitute for genes predicted to be
essential. For instance, the model predicted that the gene glpK is
non-essential due to the presence of the alternative glycerol
pathway described above. This alternative glycerol utilization
pathway has now been deleted from the GSMN-TB model.
Amongst the false negative model predictions was the malate
dehydrogenase gene mdh (Rv1240), which was identified previously
as non-essential in the original TraSH screen [8] but was identified
as essential in the TraSH analysis presented here. The non-
essentiality in the model was due to the predicted activity of ‘‘malic
enzyme’’ (malate dehydrogenase decarboxylating, mez) that
catalyses the oxidative decarboxylation of L-malate to pyruvate
and which, together with pyruvate carboxylase, can potentially
convert malate to oxaloacetate and thereby complement in-silico
mdh mutants. To confirm this result we attempted to construct mdh
KO mutants in both M. tuberculosis and M. bovis BCG. Despite
numerous attempts we were unable to delete the mdh gene even
when the transformants were recovered on 7H11 media which
contains glucose in addition to glycerol. When a second copy of
the wild type mdh gene was integrated into the attB site in the
chromosome, we could easily isolate mutant strains with deletions
in the original mdh gene demonstrating that this gene was essential
for growth on both glucose and glycerol containing medium. The
result indicates that either malic enzyme and/or pyruvate
carboxylase are not active in Roisin’s medium (at least in the
direction pyruvate to acetate). To date, activity of these enzymes
has not been demonstrated in M. tuberculosis.
Rv1099c, a fructose 1, 6 bisphosphatase (glpX) was predicted as
essential for gluconeogenesis by the GSMN but this was not
confirmed experimentally by the TraSH analysis. Rv1099c has
been shown to have GlpX activity and can complement an E. coli
mutant lacking fructose 1, 6 bisphosphatase [20]. In addition,
Rv1099c was identified as essential for in vivo growth in a mouse
model of TB by TraSH analysis [10], which is consistent with the
requirement for gluconeogenesis in vivo. It is therefore puzzling
why it is not required for growth on glycerol in vitro. The Rv2131c
gene has been shown to possess fructose-1, 6-bisphosphatase
activity in addition to inositol monophosphatase activity and could
therefore potentially substitute for glpX [21].
Genetic requirements for growth in a carbon-limited
chemostat
In order to identify genes that are important for both the control
and establishment of fast and slow growth rates competitive
chemostat cultivations were performed. The experiments were
carried out at two different growth rates (D=0.03 h
21 and
D=0.01 h
21) equivalent to doubling times (td) of 69 h and 23 h
respectively. The physiological and transcriptomic profile of BCG
cells at these growth rates have been described previously [3,4].
Subsequently, continuous cultures at a dilution rate of 0.03 h
21
were switched to a dilution rate of 0.01 h
21 and vice versa (Figure 2).
This strategy was used to identify genes important for the change
from one growth rate to another. The cultures were sampled in the
batch phase just prior to the start of continuous culture and after
, 11 generations of chemostat culture. DNA was extracted from
the surviving bacterial cells and mutant gene identity and
abundance assessed by TraSH. This analysis identified mutants
which were negatively selected for during either slow (F) (td=69 h)
(Dataset S2, Figure 3) or fast (S) (td=23 h) (Dataset S3, Figure 3)
rates and also mutants attenuated in the switch from fast to slow
(F–S) (Dataset S4) or slow to fast (S–F) (Dataset S5).
There was very little overlap between the mutants attenuated at
fast growth rate and slow growth rate (Figure 3) but five genes
Figure 1. Growth of wild type and glpK mutant strains. Colonial morphology of 3 week grown (i) wild type M. bovis BCG (ii) a glpK deletion
mutant and (iii) glpK mutant carrying a copy of the glpK gene in the attB site on the chromosome on (A) 7H11 media and (B) Roisin’s glycerol minimal
media. The glpK mutant exhibited dysgonic growth on 7H11 medium and was unable to grow on Roisin’s minimal media. The wild type phenotype
was restored in the complemented strain.
doi:10.1371/journal.pone.0005349.g001
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library of Mycobacterium bovis BCG was inoculated into the chemostat and after an initial phase in batch culture was grown at a doubling time of
23 h (D=0.03 h
21) and samples removed for analysis by transposon site hybridisation (TraSH). The transposon mutant library was similarly inoculated
into the chemostat at a growth rate corresponding to a doubling time of 69 h (D=0.01 h
21) and samples again removed for TraSH analysis. Finally,
cultures established at the fast growth rate were switched to the slow growth rate, and visa versa, to identify mutants unable to switch between the
different growth rates.
doi:10.1371/journal.pone.0005349.g002
Figure 3. Mutants with reduced fitness at (A) fast (td=23 h) and (B) slow (td=69 h) growth rate in a carbon limited chemostat. Venn
diagram shows the overlapping genes.
doi:10.1371/journal.pone.0005349.g003
BCG Growth Rate Control
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the growth rate (Figure 3). These included regX3, mmpL4 and
mmaA4 which have all been shown previously to have an
important role in the virulence of M. tuberculosis in a mouse model
but without any observed alteration in their in vitro growth rate.
The finding that they are also required for optimal growth in the
chemostat suggests that they play a role in maintaining growth in
carbon-limiting conditions. A very subtle growth defect during the
stationary phase of growth was reported for the regX3 deletion
mutant of M. tuberculosis [22] when grown in Dubos medium in
which carbon would also have been limiting growth during
stationary phase. RegX3 appears to play a role in the regulation of
phosphate acquisition in Mycobacterium smegmatis [23] but our result
provides evidence of a broader regulatory role for this gene in M.
tuberculosis. Sassetti et al, 2003 listed the transport protein MmpL4
as essential for in vitro growth; however it was demonstrated by
Domenech et al (2005) that the individual deletion strain had no in
vitro phenotype but had both impaired growth kinetics during the
acute phase of infection and also impaired lethality in a mouse
model [14]. Although several members of the MmpL group are
involved in the transport of lipids the substrate of MmpL4 is
unknown. It has been postulated that this protein is involved in
transporting host dipeptides [14], however the demonstration here
that MmpL4 is essential for growth in the minimal Roisin’s media
containing neither lipid nor peptides indicates that it is likely to
have another function.
Genes required for slow growth rate
TraSH analysis of slowly growing BCG identified 89 genes
(Dataset S2; Figure 3) important for the establishment and
maintenance of this growth rate. As has been reported previously
there was a very poor correlation between the transcriptome of
slowly growing BCG and the TraSH essentiality data [6,7]. Only 9
genes (cobQ1, purT, fprB, ctpV, Rv1227c, Rv2014, rpmG, Rv2943,
Rv3691) were required for slow growth rate that had also been
identified as transcriptionally upregulated in this condition [19].
Essential genes were divided into functional categories using the
gene ontology developed as part of the genome sequencing project
(http://www.sanger.ac.uk/Projects/M_tuberculosis/Gene_list/)
and a chi square test used to calculate functional groups with a
significant fraction of genes identified as being required for slow
growth. Nine functional categories were highlighted as being
significantly involved in slow growth: electron transport; ATP-proton
motive force; cobalamin biosynthesis; modification of fatty and mycolic acids;
degradation of RNA; conserved membrane proteins; detoxification; virulence and
other IS elements.
Several genes that appeared to be required for slow growth are
of particular note (Table 1). Genes encoding the pin domain
proteins (Rv2103c and Rv2494) were identified with mutants that
had reduced fitness at slow growth rate. These proteins are
putative toxin genes and have been proposed to play a role in
promoting slow growth during stressful environments [24].
Interestingly, mutants in two anti-toxin genes (Rv0596c and
Rv1962) were identified as having reduced fitness at the fast
growth rate. Several of the genes apparently involved in slow
growth have previously been associated with virulence, such as
(ppsA and ppsB) which are essential for the synthesis of pthioceral
dimycocerosates (DIM). DIM mutants have high cell wall
permeability and are severely attenuated in mouse models of TB
[25,26]. Several known regulators were also identified as being
involved in slow growth including the heat shock protein repressor
gene hspR. Strains of M. tuberculosis lacking hspR over-express heat
shock proteins and have defects specifically during the chronic or
persistent phase of TB infection, a feature which was proposed to
be due to enhanced immune recognition [27]. To verify the
involvement of this regulator in maintenance of slow growth,
competitive chemostat experiments were performed using M. bovis
BCG strains (wild type and DhspR). The strains grew identically
during the batch phase (results not shown) but had a significantly
reduced fitness during slow growth rate, independently confirming
the TraSH data (Figure 4). However, when the experiment was
repeated using wild type M. tuberculosis H37Rv and a M. tuberculosis
hspR KO mutant [27] the mutation conferred a growth defect
relative to the wild type strain during the batch phase of growth
whereas there was no additional reduction of fitness observed
during chemostat culture at slow growth rate (Figure 4). The result
appears to indicate a difference in growth control between M.
tuberculosis and M. bovis BCG.
Genes required for fast growth rate
Only 29 genes were attenuated for survival at the fast growth
rate (D=0.03 h
21). As the maximum growth rate (mmax)o fM.
bovis BCG in Roisin’s medium in continuous culture is 0.033
{Beste, 2005 1564/id) the fast growth rate is very close to mmax and
therefore fewer additionally essential genes would be expected.
With this relatively small number of genes it was not possible to
find any significant functional associations.
Genetic requirements for the shift from slow to fast
growth rate
A total of 256 genes were identified as important in the switch
from slow growth rate to fast. Significant functional categories
Table 1. Selected Mycobacterium bovis BCG mutants that incurred a high fitness cost during continuous culture in a carbon-
limited chemostat at different growth rates.
Input Pool Output pool Gene Name and Function
Batch Fast growth rate (td=23h) Rv0596c (antitoxin), pknH (serine-threonine protein kinase), Rv1962 (antitoxin)
Batch Slow growth rate (td=69h) hspR (heat shock regulator), Rv2103c (toxin), Rv2494 (toxin), ppsA and ppsB (DIM
biosynthesis and important in virulence), nouC and NuoN (aerobic/anaerobic
respiration), cmaA2 (cyclopropane-mycolic acid synthase)
Batch to Fast growth rate Slow growth rate Rv0485 (transcriptional regulator), MprA (mycobacterial persistence regulator), NuoE
(aerobic/anaerobic respiration), cmaA2 (cyclopropane-mycolic acid synthase, mutant
hypervirulent in mice) NuoE (aerobic/anaerobic respiration)
Batch to Slow growth rate Fast growth rate Rv0172 and lprK (part of mce1 operon), dosT (histidine kinase sensor for Dos regulon)
and sigF, sigJ, (alternative sigma factors involved in virulence and persistence), whiB1
(transcriptional regulatory protein)
doi:10.1371/journal.pone.0005349.t001
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PPE family and also the unknown function class indicating that a large
number of uncharacterized gene products are required for the shift
from slow to fast growth rate. Amongst these genes are several
regulators including the stress response sigma factors sigF and sigJ
and the transcriptional regulators whiB1 and whiB6. Although
previous studies have failed to find an in vitro growth effect for
either sigF [28,28] or sigJ [29] mutants our results indicate that the
genes are involved in the switch from slow to fast growth rate. SigF
mutants have reduced lethality in both mouse [28] and guinea pig
models [30] of TB and also have altered cell membrane properties
[31,32] whereas sigJ is dispensable for in vivo growth but appears to
be involved in protection against hydrogen peroxide [29]. The
resuscitation promoting factor gene rpfE (Rv2450c) was also
identified as being essential for the switch from slow to fast growth
rate. Resuscitation growth factors have been implicated in the
reactivation of dormant mycobacteria [33] and may also play a
role in virulence [34]. RpfE is one of five resuscitation factors
identified in M. tuberculosis and although initial studies suggested
functional redundancy more recent research suggests that these
genes may have some degree of functional specialization [34], a
notion supported by our data. RpfE has been shown to interact
with an endopeptidase and probably has a role in peptidoglycan
hydrolysis during cell division [35], a process that is likely to be
involved in the switch from slow to fast growth rate.
Fast to slow growth rate
Only 19 genes had reduced fitness during the shift from fast to
slow growth rate. Of note amongst this list was mprA, a two
component regulator which has been shown to have a role in the
entry and maintenance of a persistent infection in mice [36].
Absence of mprA also increases growth in resting macrophages
[36] and increases the expression of stress related genes [37].
Positive fitness effects
Some mutations led to enhanced growth and are therefore
positively selected in the competitive growth experiment. These
mutants were identified using rank products, ranking on the largest
positive log ratio. This generated lists of genes whose loss led to a
significant selective advantage over the wild type strain in each
condition (Dataset S6, S7, S8, S9). The most striking feature of this
data was that for three of the four conditions examined (slow, fast
and the switch from fast to slow but not the switch from slow to
fast growth) almost all the top-ranked genes belong to the mce1
operon. This was not due to simple overgrowth of a single mutant
since independent mutants representing inactivation of at least 11
of the 13 genes in the mce1 operon were over-represented in these
conditions. In addition mutations in the putative ATPase, Rv0655
which has been functionally linked to the mce1 operon [38] and
also Rv0199 and Rv0200 which are closely related to genes
present in the mce1 operon [39] also had a positive fitness affect. It
appears therefore that inactivation of any of the genes in the mce1
operon and their associated genes give rise to mutants with the
same competitive growth advantage.
This result seemed initially to be contradictory. Why would mce1
operon mutants be advantageous at slow, during the switch to
from fast to slow growth rate and at fast growth rate but not for the
switch from slow to fast growth rate? The common factor in these
three conditions is a switch from a fast to a slower growth rate.
This is still compatible with the finding that the mutants also had a
growth advantage at fast growth rate in the chemostat since this
experiment involved a shift from growing at maximal growth rate
in batch to the fast growth rate in the chemostat (which is
nevertheless slower than the rate in batch). To validate this result a
M. tuberculosis mce1 operon mutant was constructed (see methods)
and competitive chemostat experiments performed at the slow
growth rate after an initial period in batch. The results of two
independent experiments showed that although there was no
difference in fitness between the wild type and mutant during
batch culture (results not shown) the mutant had dramatic
competitive advantage at slow growth rate in the chemostat as
evidenced by the outgrowth of the mce1 mutant from a starting
mutant:WT ratio of 1 to a ratio of 100 after 35 days of continuous
culture confirming the TraSH data (Figure 5). After 35 days a
‘‘quasi steady state’’ was obtained between the wildtype and
mutant, a phenomenon which has been described previously in
chemostat cultures [40]. The reasons for the maintenance of
competing strains in the chemostat remains controversial and is
subject to continuing mathematical investigation [41,42]. When
the dilution rate was then switched to a fast growth rate the
selective advantage was lost, the wild type recovered and both
strains returned to approximately equivalent amounts (Figure 5).
The ability of the wild type to recover at fast growth rate in this
competition was intriguing and unexpected. However, the system
becomes dynamic after the shift in the dilution rate and so the
growth rate of both strains will depend on factors not apparent in
steady state cultures. These observations may provide a clue to the
function of the mce1 operon but require further focused
investigations.
The mce1 operon has been the centre of much research and
debate. Interest in this operon dates back to 1993 when Arruda et
al demonstrated that mce1A was able to transfer to Escherichia coli
the ability to invade eukaryotic cells [43]. The genome sequencing
project revealed that the mce1A gene is part of an operon of 13
genes and that this operon is duplicated four times (mce2, mce3,
mce4) in the genome of M. tuberculosis [44]. The role of the genes in
M. tuberculosis remains highly controversial although there is an
increasing consensus that each operon (which resembles a multi-
subunit ABC transport system) encodes a transporter system. The
mce4 locus has recently been shown to be involved in the transport
of cholesterol [38,45]. However, the role of mce1 remains
mysterious. Riley and colleagues have reported a hypervirulent
phenotype for mce1 gene knock-outs in a murine model of TB
[46,47]; whereas a transposon mce1 mutant used by Sassetti and
Rubin (2003) and also Joshi et al (2006) [38] had a growth defect in
early infection in competition experiments. An in vitro phenotype
Figure 4. Competitive chemostat experiments: Wild type Vs
Dhspr. Average CFU ratios of (i) wild type H37Rv+DhspR (closed circles)
and wild type BCG+DhspR (closed triangles) during continuous culture
at a dilution rate of 0.01 h
21 (td=69 h) were plotted as a function of
time. Data were normalized so that the ratio at the start of chemostat
culture equaled 1. Only the BCG DhspR strain was attenuated for slow
growth rate in the chemostat.
doi:10.1371/journal.pone.0005349.g004
BCG Growth Rate Control
PLoS ONE | www.plosone.org 6 April 2009 | Volume 4 | Issue 4 | e5349for mce1 mutants has not previously been reported but our results
show that mce1 mutants have a competitive advantage over wild
type strains during the switch to slow growth rate in a carbon
limited chemostat.
Our finding that mce1 mutants are overrepresented inslow growth
rate cultures is both intriguing and puzzling. The finding has some
similarities to ‘evolutionary cheating’ in E. coli whereby mutants that
fail to enter, or exit early from, the non-dividing stationary phase
state are overrepresented in stationary phase cultures [48]. We posit
a similar scenario for M. tuberculosis whereby (for unknown reasons)
mce1 mutants are unable to enter, or exit early from, the slow growth
rate state and are thereby overrepresented in slow growth rate
cultures. This hypothesis is consistent with data showing that mce1
expression is turned off initially during murine infection but is then
switchedbackonina later stage ofinfection [49]. If this hypothesis is
correct then the underlying mechanism may be involved in the
observed hypervirulent phenotype of the mce1 knock out strain in vivo
[46] and could have implications for understanding the switch from
acute to persistent infections in the host.
Conclusion
The data presented here demonstrate that maintaining growth
at slow and fast growth rate and switching between these states is a
carefully controlled process in mycobacteria involving a unique set
of genes and not simply acceleration or deceleration of the same
cellular processes. Several of these genes are transcriptional
regulators (such as hspR) and many have previously been
implicated as involved in virulence including persistence. The
results indicate that growth control in M. tuberculosis is a complex
process and that the phenomenon of growth control, as measured
in the chemostat, may have relevance to virulence (including
persistence) in the host. Many of the genes that we identified as
involved in growth control in the chemostat have not previously
been associated with any phenotype in vitro and therefore the
results potentially also provide a fruitful experimental route
towards unraveling the role of M. tuberculosis genes whose function
is currently unknown. Perhaps the most surprising finding of this
study was the demonstration that the mce1 operon is involved in
growth control of M. tuberculosis. This result is very interesting but
begs the question: how does mce1 influence growth? Whilst our
experiments do not identify what this role is they do provide a
means to study this phenomenon in vitro.
Materials and Methods
Chemostat cultivations
A library of transposon mutants constructed in M. bovis BCG
Pasteur was kindly provided by Eric J. Rubin [8]. An aliquot of the
transposon insertion library was cultured in Roisin’s minimal
medium, without the addition of biotin [3] until an OD600 of 1.0.
This pre-culture was transferred into a 2 L bioreactor as previously
described [3]. After inoculation the culture was grown as a closed
system until the OD600 reached approximately 1.0. Continuous
culturing was then started at a known dilution rate of 0.03 h
21
(equivalent to a doubling time [td]o f2 4h )o r0 . 0 1h
21 (td=69 h).
Six to eight volume changes were allowed for selection of mutants
with growth defects or enhanced survival at each dilution rate.
Culture samples were harvested from the chemostat in the batch
phase and during continuous culture and used to isolate genomic
DNA. Cultures established at the fast growth rate were switched to
the slow growth rate, and vice versa in order to identify mutants
unable to switchbetween different growth rates (Figure 1).Genomic
DNA was extracted from independent triplicate or quadriplate
chemostat cultures using standard methods. TRASH probes were
generated using the protocol described by Sassetti et al (2001).
For the competitive chemostat cultivations of individual mutant
versus wild type equivalent amounts of antibiotic tagged mutant
and wild type strains were inoculated into bioreactors and grown
at a dilution rate of 0.01 h
21 or 0.03 h
21. Samples were removed
from the chemostat once every generation during continuous
culture. The numbers of wild type and mutant bacteria were
determined by plating serially diluted samples onto 7H11 agar (for
total bacterial counts) and 7H11 agar containing hygromycin at
50 mgm l
21 (to enumerate the cfu of the mutant).
Microarrays and hybridizations
Fluorescently labeled cDNA were produced by reverse
transcription of the TRASH probes (1 mg) with Superscript II
(Invitrogen) in the presence of Cy3-dCTP (Amersham Pharmacia)
using random hexamer oligonucleotides to prime cDNA synthesis.
The reference control sample of Cy-3 labeled genomic DNA used
for the glycerol minimal media experiments was prepared by
mixing Cy3-labeled dCTP and BCG genomic DNA with Klenow
DNA polymerase in the presence of random primers. The reaction
was incubated for a minimum of 90 minutes at 37uC and the
labeled DNA purified using a Qiagen MiniElute column.
The DNA microarrays provided by the Bacterial Microarray
Group at St Georges (http://bugs.sgul.ac.uk/index.php) were
constructed from PCR-amplified ORF-specific DNA, representing
all of the predicted open reading frames from the M. tuberculosis
H37Rv genome spotted in duplicate. The array designs are available
in BmG@Sbase (Accession No. A-BUGS-1 and A-BUGS-2; http://
bugs.sgul.ac.uk/A-BUGS-1) and also ArrayExpress (Accession
No. A-BUGS-1 and A-BUGS-2). Pre-hybridisation, hybridisation
and washing were performed as described by Stewart et al. [50].
Figure 5. Competitive chemostat experiments: Wild type M.
tuberculosis Vs Dmce1 operon. (A) Average CFU ratios of wild type
H37Rv and Dmce1 operon during continuous culture at a dilution rate
of 0.01 h
21 (td=69 h) were plotted as a function of time. Data were
normalized so that the ratio at the start of chemostat culture equaled 1.
The mce1 operon mutant had a competitive advantage over the wild
type strain at slow growth rate. The graph is representative of two
independent experiments. (B) At day 53 the dilution rate was altered to
0.03 h
21 (td=23 h). At fast growth the Dmce1 did not have a
competitive advantage over the wild type strain and the ratio returned
to 2 after only 11 days at a dilution rate of 0.03 h
21 (td=23 h).
doi:10.1371/journal.pone.0005349.g005
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Microarrays were scanned using a 428 Array Scanner
(Affymetrix). Fluorescence intensity data from each array were
automatically quantified using BlueFuse for microarrays (version
3.3) software (Bluegnome). The spot confidence was also evaluated
by Bluefuse and low quality spots (flag E) were rejected. Duplicate
spots were averaged and filtered so that only genes for which there
was a value for at least 4 replicates were statistically analysed.
Microarray data were analysed by the Rank Product analysis
[11] using the Bioconductor package RankProd [51] in R
[52].This generates a lists of genes ranked according to log ratio
and also calculates a conservative estimate of the percentage of
false positives (pfp) or false discovery rate (FDR). The pfp considers
the problem of multiple testing and does not require an additional
correction method. The genes with PFP values smaller than 0.1
(10%) were regarded as differentially represented. Fully annotated
microarray data have been deposited in BmG@Sbase (accession
number E-BUGS-83; http://bugs.sgul.ac.uk/E-BUGS-83) and
also ArrayExpress (accession number E-BUGS-83).
Genetic manipulations
For the construction of mdh, glpK and mce1 mutants, E. coli strain
DH5a was grown in solid or liquid Luria-Bertani (LB) medium as
described by Sambrook et al. [53]. M. bovis BCG cells were
propagated in Middlebrook 7H9 broth or 7H11 agar containing
5% (v/v) OADC enrichment media supplement (Becton Dick-
enson), 0.5% glycerol plus 0.05% Tween 80 for liquid cultures.
For mycobacteria, when selection was required, kanamycin at
20 mgm l
21, X-gal at 50 mgm l
21, hygromycin at 50 g ml
21 and
sucrose at 2% (w/v) were added to the culture media.
Mutants of M. bovis BCG and M. tuberculosis were constructed
using the strategy described by Stewart et al, 2001. Approximately
1 kb regions flanking mdh and glpK were amplified by PCR using
the Roche Expand High Fidelity PCR system. Fragments were
cloned either side of the hygromycin cassette into the suicide
vector pG5, which is a pSMT100 [27] plasmid carrying a
kanomycin resistance gene in addition to the sacB counter-
selectable marker. The resulting plasmid was electroporated into
M. tuberculosis H37Rv and M. bovis BCG as described previously
[54]. Double crossovers were selected for on 7H11 agar
supplemented with kanamycin, hygromycin and X-gal. To restore
the wild-type phenotype a cloned glpK gene was reintroduced into
DglpK M. bovis BCG and DglpK M. tuberculosis on the pKinta
plasmid [50]. To facilitate the inactivation of the mdh gene, a
diploid strain was constructed by integrating a second copy of the
gene at the attB site [50]. Deletion of the chromosomal copy of mdh
was performed as described above. PCR and Southern analysis
were performed to verify the expected genotypes.
The mce1 operon was disrupted in M. tuberculosis strain H37Rv
using a suicide vector kindly provided by Lee Riley and the two
step counter selection cloning strategy described by Parish and
Stoker [54]. This vector targets the gene Rv0168. It was previously
demonstrated that Rv0168 mutants do not express any of the
genes in the mce1 operon [46]. Potential mutants were verified by
PCR and Southern blot hybridization.
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